Back to 
Qube Research & Technologies Ltd
Qube Research & Technologies Ltd
VVOS
Showing 0 of 2 quarters
Position history for Qube Research & Technologies Ltd's holdings in Vivos Therapeutics, Inc.
No. Qube Research & Technologies exited its VVOS (Vivos Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 200 shares worth $38. Qube Research & Technologies first reported VVOS in Q3 2023 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of VVOS: Royce & Associates LP, Russell Investments Group, Ltd., Walleye Capital LLC